72 related articles for article (PubMed ID: 2641256)
1. AZT benefits HIV-positive asymptomatic people: new hope, new challenges.
Lewis A
AIDS Educ Prev; 1989; 1(4):347. PubMed ID: 2641256
[No Abstract] [Full Text] [Related]
2. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
3. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
4. AZT in pregnant women with HIV: risks and benefits.
Doyle VB
Neonatal Netw; 1995 Mar; 14(2):62-3. PubMed ID: 7746241
[No Abstract] [Full Text] [Related]
5. Zidovudine in asymptomatic HIV infection.
Martinez R
N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 7902535
[No Abstract] [Full Text] [Related]
6. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
7. [AZT in community practice].
Bary M; Mettetal JF
Therapie; 1989; 44(6):413-5. PubMed ID: 2623656
[TBL] [Abstract][Full Text] [Related]
8. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
[TBL] [Abstract][Full Text] [Related]
9. Pediatric treatment update.
Grubman S
GMHC Treat Issues; 1996 Mar; 10(3):7-9. PubMed ID: 11363392
[TBL] [Abstract][Full Text] [Related]
10. [Open questions about HIV/AZT].
Garattini S
Riv Inferm; 1994; 13(2):104-6. PubMed ID: 7863189
[No Abstract] [Full Text] [Related]
11. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modelling of chemotherapy in HIV infection.
Hraba T; Dolezal J
Folia Biol (Praha); 1994; 40(3):103-11. PubMed ID: 7805931
[TBL] [Abstract][Full Text] [Related]
13. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H
Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615
[TBL] [Abstract][Full Text] [Related]
14. [Zidovudine for asymptomatic HIV patients?].
Flepp M
Dtsch Med Wochenschr; 1994 Oct; 119(40):1374-5. PubMed ID: 7924945
[No Abstract] [Full Text] [Related]
15. [Progression of HIV infection halved: early AZT therapy--advantage confirmed in a large European-Australian study].
Toeller V
Pharm Unserer Zeit; 1993 Nov; 22(5-6):263. PubMed ID: 8121928
[No Abstract] [Full Text] [Related]
16. Zidovudine in asymptomatic HIV infection.
Phillips AN; Sabin CA
N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 8247049
[No Abstract] [Full Text] [Related]
17. Education needed after AZT failure.
Nurs Stand; 1993 Apr 7-13; 7(29):6. PubMed ID: 8499278
[No Abstract] [Full Text] [Related]
18. Combination 3TC/AZT therapy shows promise.
AIDS Clin Care; 1995 Mar; 7(3):22. PubMed ID: 11362192
[TBL] [Abstract][Full Text] [Related]
19. Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
Needham DM
Hum Health Care Int; 1997; 13(3):E11. PubMed ID: 14986616
[No Abstract] [Full Text] [Related]
20. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
